Cargando…

Smoking, ACE-2 and COVID-19: ongoing controversies

Smoking increases severity of COVID-19 https://bit.ly/2yWp3jb

Detalles Bibliográficos
Autores principales:	Leung, Janice M., Sin, Don D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Agora
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363948/ https://www.ncbi.nlm.nih.gov/pubmed/32430431 http://dx.doi.org/10.1183/13993003.01759-2020

Ejemplares similares

COVID-19 and nicotine as a mediator of ACE-2
por: Leung, Janice M., et al.
Publicado: (2020)

Reply to: “Current smoking is not associated with COVID-19”
por: Leung, Janice M., et al.
Publicado: (2020)

ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
por: Leung, Janice M., et al.
Publicado: (2020)

Could the smoking gun in the fight against COVID-19 be the (rh)ACE-2?
por: Lutchman, Dhamend
Publicado: (2020)

Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences
por: Patel, Sheila K., et al.
Publicado: (2021)

Current smoking is not associated with COVID-19
por: Rossato, Marco, et al.
Publicado: (2020)

mTORC1 hyperactivation in lymphangioleiomyomatosis leads to ACE2 upregulation in type II pneumocytes: implications for COVID-19
por: Tang, Yan, et al.
Publicado: (2021)

COVID-19 and smoking: is nicotine the hidden link?
por: Russo, Patrizia, et al.
Publicado: (2020)

Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial
por: Milne, Stephen, et al.
Publicado: (2021)

Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects
por: Jacobs, Merel, et al.
Publicado: (2020)

Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication
por: Chen, Mengfei, et al.
Publicado: (2020)

Smoke-free vehicles: impact of legislation on child smoke exposure across three countries
por: Laverty, Anthony A., et al.
Publicado: (2021)

Universal use of face masks for success against COVID-19: evidence and implications for prevention policies
por: Esposito, Susanna, et al.
Publicado: (2020)

Response to COVID-19 phenotyping correspondence
por: Bos, Lieuwe D.J., et al.
Publicado: (2020)

P(aO(2))/F(IO(2)) ratio: the mismeasure of oxygenation in COVID-19
por: Tobin, Martin J., et al.
Publicado: (2021)

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
por: Yang, Hai-Jun, et al.
Publicado: (2020)

COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?
por: McAlinden, Kielan Darcy, et al.
Publicado: (2020)

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
por: Du, Rong-Hui, et al.
Publicado: (2020)

Autoimmunity to annexin A2 predicts mortality among hospitalised COVID-19 patients
por: Zuniga, Marisol, et al.
Publicado: (2021)

Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights
por: Wark, Peter A.B., et al.
Publicado: (2021)

The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19
por: Klok, Frederikus A., et al.
Publicado: (2020)

COVID-19 phenotypes: leading or misleading?
por: Gattinoni, Luciano, et al.
Publicado: (2020)

Healthcare workers with COVID-19 in Mexico
por: Ñamendys-Silva, Silvio A.
Publicado: (2020)

On tuberculosis and COVID-19 co-infection
por: Tadolini, Marina, et al.
Publicado: (2020)

COVID-19 and the nicotinic cholinergic system
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

Proteinase release from activated neutrophils in mechanically ventilated patients with non-COVID-19 and COVID-19 pneumonia
por: Seren, Seda, et al.
Publicado: (2021)

A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19
por: Singh, Dave, et al.
Publicado: (2021)

Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients
por: Yu, Hai-qiong, et al.
Publicado: (2020)

COVID-19 prediction models should adhere to methodological and reporting standards
por: Collins, Gary S., et al.
Publicado: (2020)

The potential impact of COVID-19-related disruption on tuberculosis burden
por: McQuaid, C. Finn, et al.
Publicado: (2020)

Face masks, respiratory patients and COVID-19
por: Soriano, Joan B., et al.
Publicado: (2020)

The (in)significance of TB and COVID-19 co-infection
por: Khurana, Alkesh Kumar, et al.
Publicado: (2020)

Correlation and causality: a COVID-19 conundrum
por: Morice, Alyn H.
Publicado: (2020)

Pulmonary embolism in patients with COVID-19 pneumonia
por: Bompard, Florian, et al.
Publicado: (2020)

Is high-dose glucocorticoid beneficial in COVID-19?
por: Muthu, Valliappan, et al.
Publicado: (2021)

The value of chest CT as a COVID-19 screening tool in children
por: Merkus, Peter J.F.M., et al.
Publicado: (2020)

Remote monitoring of oxygen saturation in individuals with COVID-19 pneumonia
por: O'Carroll, Orla, et al.
Publicado: (2020)

Does chemotherapy reactivate SARS-CoV-2 in cancer patients recovered from prior COVID-19 infection?
por: Bi, Jianping, et al.
Publicado: (2020)

Increased focus on non-animal models for COVID-19 and non-COVID lung research
por: Gribaldo, Laura, et al.
Publicado: (2021)

Home monitoring reduced short stay admissions in suspected COVID-19 patients: COVID-box project
por: Dirikgil, Ebru, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_37miinbgmrco0l4o98sl6q27uv